Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ENTX · NASDAQ · Biological Products, (No Diagnostic Substances)
$3.00−0.02 (−0.66%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Entera Bio (ENTX) · oqro.io/stocks/ENTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Spruce Street Capital LP now owns 6.4% of ENTX as a passive investorSource5%+ stake · Stake as of Oct 23, 2026 · Filed Oct 30, 2026
Venrock Healthcare Capital Partners III, L.P. now owns 5.1% of ENTX as a passive investorSource